Pointers with Dr Portela: New FDA Treatment for Alopecia Areata

In this week’s Pointers with Dr Portela, the 208SkinDoc talks the newest approval of baricitinib (Olumiant; Eli Lilly and Company) for the treatment of alopecia areata.

Dustin Portela, DO, a board-certified dermatologist and dermatologic surgeon at Treasure Valley Dermatology in Boise, Idaho, talks the FDA approval of baricitinib (Olumiant; Eli Lilly and Company) for the treatment of alopecia areata. He talked about the data and explained the adverse events seen with this treatment.

Opinions expressed are that of Portela and do not express the views or opinions of Dermatology Times®.